Cancer Commissioning Strategy Framework | 3 2 | Cancer Commissioning Strategy Framework Contents Introduction and Strategic Aims for Cancer 3 The Role of Commissioning 4 Cancer Commissioning: Key Responsibilities and Fragile Services Framework 5-7 National Cancer Commissioning Landscape 8-9 North Central London Strategic Landscape 10-11 The NCL Cancer Commissioning Wheel 12-13 Cancer Commissioning Intentions 14 Appendices 15-26 Appendix 1 NCL High-Level Cancer Commissioning Intentions for 2025-2026 - Implementation Plan Appendix 2 Developing a Methodological Framework to Facilitate a Strategic Review of Fragile Cancer Services Appendix 3 Fragile Services Framework Appendix 4 Tumour Specific ERG Cancer Fragility Risk Checklist Appendix 5 Commissioning Tools, Templates and Resources Directory Acknowledgment 27 Introduction The North Central London Cancer Commissioning Guide & High-Level Intentions document provides a comprehensive roadmap for the commissioning of cancer services across the region. It sets out the national and local strategic landscape, aligning with key NHS priorities to drive early diagnosis, improve patient outcomes and reduce health inequalities. This document also outlines the high-level commissioning intentions for 2025/26. A key feature of this commissioning guide is the NCL Cancer Commissioning Wheel, which clarifies the annual commissioning cycle, ensuring a structured, data-driven approach to service improvement. It outlines how services will be planned, delivered, and evaluated to ensure quality, innovation and sustainability. Recognising the need to future-proof cancer services, this commissioning guide integrates a methodological framework for reviewing fragile services. Developed through extensive stakeholder engagement—including one-to-one consultations, expert reference groups and collaborative workshops—the fragile services framework provides a structured approach to identifying areas of service vulnerability, assessing risks and implementing targeted interventions. Through the integration of evidence-based commissioning, financial sustainability measures and strategic workforce planning, this commissioning guide outlines how cancer services in North Central London will remain patient-centred, highperforming and resilient in the face of evolving healthcare demands. NCL Cancer Alliance Strategic Aims 1. Improve Survival (SA1): Prioritise early diagnosis, intervention, and prevention. 2. Enhance Patient Experience (SA2): Deliver the highest standards of patient care and improve quality of life. 3. Operational Efficiency (SA3): Ensure sustainable, innovative cancer diagnostic and treatment services. 4. Address Health Inequalities (SA4): Reduce disparities in access and outcomes across all population groups. 5. Workforce Excellence (SA5): Ensure that we have a well-trained, competent workforce delivering high-quality care. 6. Foster Innovation (SA6): Promote innovative approaches in cancer diagnostics, care, and treatment. Cancer Commissioning
RkJQdWJsaXNoZXIy NTI5NzM=